Safety evaluation of bleomycin in ovarian cancer treatment: A pharmacovigilance analysis using Food and Drug Administration adverse event reporting system data.

J Int Med Res · 2026 · PMC13389179 · PMID 42478093

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Among these, we captured a highly significant signal for leukemia/acute myeloid leukemia (AML) (ROR = 10.71, 95% CI: 4.8–23.87).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.